DTIL Precision BioSciences to present PBGENE-HBV at AASLD 2026
DTIL Precision BioSciences announced a late-breaking oral presentation for PBGENE-HBV at AASLD The Liver Meeting 2026.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
DTIL Precision BioSciences announced a late-breaking oral presentation for PBGENE-HBV at AASLD The Liver Meeting 2026.
Precision BioSciences said it was selected to deliver a late-breaking oral presentation at The Liver Meeting 2026, covering PBGENE-HBV.